Leadership
Our proven executive team brings deep, diverse cell therapy experience and is committed to developing safe, effective, and accessible NK cell therapies to patients. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.
Kenneth Kalunian, M.D.
Professor of Medicine at UC San Diego and Director of the Lupus Research and Clinical Center of Excellence
Jill Buyon, M.D.
Professor of Rheumatology and Director of the Division of Rheumatology at New York University (NYU) School of Medicine, and Director of the NYU Lupus Center
Maureen McMahon, M.D.
Professor of Medicine / Rheumatology at UCLA and Site Director of the UCLA Lupus Clinical Trials Network
Brad Rovin, M.D.
Professor of Medicine and Pathology and Director of the Division of Nephrology at The Ohio State University, Wexner Medical Center
Evren Alici, M.D., Ph.D.
Head of Cell and Gene Therapy, Karolinska Institute
Richard Maziarz, M.D.
Medical Director, Blood and Marrow Transplant and Cellular Therapy, Oregon Health & Science University
Peter Flynn, Ph.D.
Cofounder and Strategic Advisor
Thorsten Graef, M.D., Ph.D.
Strategic Advisor